Cabaletta Bio (CABA) Accumulated Expenses (2018 - 2025)

Cabaletta Bio's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $19.3 million for Q4 2025.

• On a quarterly basis, Accumulated Expenses rose 58.34% year-over-year to $19.3 million in Q4 2025; TTM through Dec 2025 was $19.3 million, a 58.34% increase from a year earlier, with the FY2025 full-year figure at $19.3 million, up 58.34% from the prior year.
• Accumulated Expenses climbed to $19.3 million in Q4 2025 per CABA's latest filing, from $6.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $19.3 million in Q4 2025 and bottomed at $891000.0 in Q1 2022.
• The 5-year median for Accumulated Expenses is $4.4 million (2021), against an average of $5.4 million.
• Across the five-year window, Accumulated Expenses tumbled 66.99% in 2022 and soared 255.67% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $3.0 million in 2021, then increased by 18.07% to $3.5 million in 2022, then soared by 124.38% to $7.9 million in 2023, then surged by 54.53% to $12.2 million in 2024, then soared by 58.34% to $19.3 million in 2025.
• Per Business Quant, the three latest CABA Accumulated Expenses figures stand at $19.3 million (Q4 2025), $6.8 million (Q3 2025), and $5.5 million (Q2 2025).